跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial
Approved
STANDARD
COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial
Roche Products Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
090f0ba1df4e2e0d
Company
Roche Products Pty Ltd
Type
Standard
Approval Details
Approval Id
090f0ba1df4e2e0d
Product Name
COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial
Artg Id
392331
Artg Name
COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial
Sponsor
Roche Products Pty Ltd
Company Detail Path
/organization/roche-products-pty-ltd
Artg Date
2023-08-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
REP
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/df402656a64cae3b69a2827bde5fc554.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/100854c67b23fa8a63c87dc201d52142.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
090f0ba1df4e2e0d
Type
Standard
Back to TGA Approvals